Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
PHASE III TRIAL TO PRESERVE THE LARYNX: INDUCTION CHEMOTHERAPY AND RADIATION THERAPY VERSUS CONCOMITANT CHEMOTHERAPY AND RADIATION THERAPY VERSUS RADIATION THERAPY
Sponsor: Eastern Cooperative Oncology Group
This PHASE3 trial investigates Head and Neck Cancer and is currently completed. Eastern Cooperative Oncology Group leads this study, which shows 7 recorded versions since 1992 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
May 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — May 2023 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Aug 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eastern Cooperative Oncology Group
- National Cancer Institute (NCI)
- Radiation Therapy Oncology Group
- SWOG Cancer Research Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Boston, United States, Cleveland, United States, Decatur, United States, Denver, United States, Des Moines, United States, East Orange, United States, Hackensack, United States, Indianapolis, United States, Kalamazoo, United States, Peoria, United States and 6 more location s